by ADRIAN MANZ | Aug 7, 2025 | The Doctor's Dose
AMD Earnings Report Q2 2025: Revenue Beats, AI Demand Surges Advanced Micro Devices (NASDAQ: AMD) delivered a mixed second-quarter earnings report Tuesday, posting better-than-expected revenue alongside in-line earnings—but the stock fell as investors digested the...
by ADRIAN MANZ | Aug 6, 2025 | The Doctor's Dose
Trump Tariffs Trigger Historic Crash in U.S. Copper Market In a stunning reversal that jolted metals markets, President Trump announced a 50% tariff on copper products—but exempted raw copper materials, sparking a 20% plunge in U.S. copper futures on Wednesday. If...
by ADRIAN MANZ | Aug 6, 2025 | The Doctor's Dose
Apple Commits $100 Billion More to U.S. Investment Amid Trade Shifts Focus Keyphrase: Apple U.S. investment 2025Apple CEO Tim Cook appeared alongside President Donald Trump in the Oval Office Wednesday to announce a significant expansion of Apple’s U.S. investment...
by ADRIAN MANZ | Aug 6, 2025 | The Doctor's Dose
Lyft Q2 Earnings Report Misses Raises Growth Concerns Lyft’s Q2 earnings report has triggered a fresh wave of investor concern, as the company posted mixed results that underscored its struggle to close the gap with its larger rival, Uber. Despite beating expectations...
by ADRIAN MANZ | Aug 6, 2025 | The Doctor's Dose
Trump Hits India With 50% Tariff Over Russian Oil Ties: What Traders Should Watch Now In a bold escalation of his foreign trade strategy, President Donald Trump announced Wednesday that the United States will impose an additional 25% tariff on goods imported from...
by ADRIAN MANZ | Aug 6, 2025 | The Doctor's Dose
Rivian Warns of Bigger Losses as EV Headwinds Mount: What Traders Need to Know Shares of Rivian Automotive (RIVN) fell over 4.5% in after-hours trading Tuesday, following a disappointing earnings release and a revised full-year loss forecast that reflects growing...
by admin | Aug 5, 2025 | The Doctor's Dose
Powell Interest Rate Strategy Explained for Investors As the Federal Reserve held interest rates steady once again this July, Fed Chair Jerome Powell took to the podium with a now-familiar tone: cautious, data-dependent, and firmly noncommittal. Behind the curtain of...
by ADRIAN MANZ | Aug 4, 2025 | The Doctor's Dose
Stagflation Isn’t Coming Back The term “stagflation” has resurfaced in economic headlines, drawing comparisons to the 1970s—an era of surging prices, weak growth, and high unemployment. But while stagflation fears in 2025 are understandable amid rising tariffs and a...
by ADRIAN MANZ | Aug 3, 2025 | The Doctor's Dose
Disney’s Next Act: Moving On From a Lost Decade A decade ago, Walt Disney Co. was rocked by the beginning of a massive media disruption. On August 4, 2015, the company slashed forecasts due to falling subscriber counts at ESPN—then its most lucrative asset. The stock...
by ADRIAN MANZ | Aug 2, 2025 | The Doctor's Dose
Meme Stocks, One-Day Options, FOMO: Is a Market Top Near? By all outward appearances, the markets are thriving. The S&P 500, Nasdaq Composite, and Dow Jones are notching record highs. But under the surface, troubling signs are flashing—signs that veterans of...
